ProVerum
4 known investors
Prover Medical develops the ProVee System, a retrievable nitinol stent and delivery device that opens the obstructed prostatic urethra to relieve lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH) without cutting, heating, or removing prostate tissue. The device is positioned as a first-line interventional therapy for urologists treating enlarged prostate.
Founders & leadership
DC
Dr Conor HarkininCo-Founder and CSOA medical doctor with an MBA whose background spans medical technology, surgery, radiology, healthcare IT, private equity, and venture capital. He co-founded ProVerum Medical, which develops a medical device for treating benign prostatic hyperplasia.
RN
Ríona Ní GhriallaisinCo-founder · Chief Technology OfficerRíona Ní Ghriallais is a biomedical engineer and co-founder and CTO of ProVerum, where she works on a minimally invasive technology for treating symptomatic benign prostatic hyperplasia (BPH).
Investors · 4
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BAug 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does ProVerum do?
- Prover Medical develops the ProVee System, a retrievable nitinol stent and delivery device that opens the obstructed prostatic urethra to relieve lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH) without cutting, heating, or removing prostate tissue. The device is positioned as a first-line interventional therapy for urologists treating enlarged prostate.
- Who founded ProVerum?
- ProVerum was founded by Dr Conor Harkin, Ríona Ní Ghriallais.
- Who are ProVerum's investors?
- ProVerum's investors include Lightstone Ventures, OrbiMed, Ireland Strategic Investment Fund, MVM Life Science Partners.